在疫情期间调查伊朗多发性硬化症患者中COVID-19诱导的适应障碍
Elahe Samami1, Seyed Mohammad Baghbanian2,3, Seyedeh Zeynab Hossein Nezhad1
1Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Neuropsychopharmacology reports
|May 2, 2025
概括
COVID-19显著影响了伊朗多发性硬化症 (MS) 患者,导致适应障碍 (AD) 的中度水平. 性别,职业和COVID-19相关的干扰等因素与AD风险增加有关.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19大流行,人们普遍担心身体和心理健康问题.
- 适应障碍 (AD) 是一种严重的并发症,特别是在弱势群体中.
- 多发性硬化症 (MS) 患者代表了一群在流行病期间潜在地面临更高心理痛苦风险的群体.
研究的目的:
- 调查伊朗多发性硬化症 (MS) 患者中COVID-19诱导的适应障碍 (AD) 的患病率和相关因素.
- 为了确定与AD相关的特定的人口,临床和流行病相关的变量.
主要方法:
- 在2020年2个月内对247名伊朗MS患者进行了一项横截面研究.
- 在线调查使用Porsline进行,包括社会人口统计医学形式和适应障碍新模块 (ADNM).
- 数据使用SPSS统计软件 (版本26) 进行分析.
主要成果:
- 多发性硬化患者的平均年龄为36.10±8.07岁,82.6%为女性.
- 平均AD得分为44.09±13.89,表明适应障碍的中等水平.
- 在AD和性别,职业,精神病史,COVID-19相关的干扰 (取消预约,药物短缺),感染史和与COVID-19相关的恐惧/担忧之间发现了显著的关联.
结论:
- 在COVID-19大流行期间,伊朗多发性硬化症 (MS) 患者中适度普遍存在适应障碍 (AD).
- 特定变量,包括人口和流行病相关因素,在这个队列中与AD有显著的关联.
- 建议进行多中心研究,以便在临床实践中对患有精神疾病的多发性硬化症患者进行强有力的查和支持策略.
相关概念视频
Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...


